Alterity Therapeutics Limited (PRNAF)
OTCMKTS · Delayed Price · Currency is USD
0.0070
+0.0040 (133.33%)
At close: Sep 23, 2025

Alterity Therapeutics Statistics

Total Valuation

PRNAF has a market cap or net worth of 63.39 million. The enterprise value is 37.16 million.

Market Cap63.39M
Enterprise Value 37.16M

Important Dates

The last earnings date was Wednesday, October 29, 2025.

Earnings Date Oct 29, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 10.88B
Shares Outstanding n/a
Shares Change (YoY) +75.31%
Shares Change (QoQ) +40.78%
Owned by Insiders (%) 5.50%
Owned by Institutions (%) 32.84%
Float 8.23B

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 17.78
PB Ratio 2.28
P/TBV Ratio 2.28
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -4.67
EV / Sales 10.55
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.98, with a Debt / Equity ratio of 0.00.

Current Ratio 12.98
Quick Ratio 12.62
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -43.23% and return on invested capital (ROIC) is -32.43%.

Return on Equity (ROE) -43.23%
Return on Assets (ROA) -28.09%
Return on Invested Capital (ROIC) -32.43%
Return on Capital Employed (ROCE) -34.50%
Revenue Per Employee 396,200
Profits Per Employee -884,914
Employee Count9
Asset Turnover 0.17
Inventory Turnover n/a

Taxes

In the past 12 months, PRNAF has paid 44,617 in taxes.

Income Tax 44,617
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +94.44% in the last 52 weeks. The beta is 0.05, so PRNAF's price volatility has been lower than the market average.

Beta (5Y) 0.05
52-Week Price Change +94.44%
50-Day Moving Average 0.01
200-Day Moving Average 0.02
Relative Strength Index (RSI) 49.34
Average Volume (20 Days) 9,434

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, PRNAF had revenue of 3.57 million and -7.96 million in losses. Loss per share was -0.00.

Revenue3.57M
Gross Profit 3.48M
Operating Income -9.61M
Pretax Income -7.92M
Net Income -7.96M
EBITDA -9.59M
EBIT -9.61M
Loss Per Share -0.00
Full Income Statement

Balance Sheet

The company has 26.66 million in cash and 101,919 in debt, giving a net cash position of 26.55 million.

Cash & Cash Equivalents 26.66M
Total Debt 101,919
Net Cash 26.55M
Net Cash Per Share n/a
Equity (Book Value) 27.80M
Book Value Per Share 0.00
Working Capital 27.76M
Full Balance Sheet

Cash Flow

Operating Cash Flow -7.51M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 97.66%, with operating and profit margins of -269.57% and -223.35%.

Gross Margin 97.66%
Operating Margin -269.57%
Pretax Margin -222.10%
Profit Margin -223.35%
EBITDA Margin -269.05%
EBIT Margin -269.57%
FCF Margin n/a

Dividends & Yields

PRNAF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -75.31%
Shareholder Yield -75.31%
Earnings Yield -12.56%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

PRNAF has an Altman Z-Score of 1.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.05
Piotroski F-Score 3